You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創醫療(00853.HK)預計心脈醫療科技2019年歸母淨利同比增加45%到65%
格隆匯 01-21 22:03

格隆匯1月21日丨微創醫療(00853.HK)公告,心脈醫療科技為一家於科創板上市公司。於本公告日期,公司持有心脈醫療科技已發行股本約46.34%及其業績與公司財務業績綜合入賬。

上海微創心脈醫療科技股份有限公司2019年年度業績預增。經財務部門初步測算,預計2019年年度實現歸屬於母公司所有者的淨利潤為1.31億元到1.49億元,與上年同期(法定披露數據)相比,將增加4079.16萬元到5892.11萬元,同比增加45%到65%。

報告期內,公司始終聚焦主業,各項業務有序開展,不斷完善產品線佈局,加大市場開拓力度,新產品Castor分支型主動脈復膜支架及輸送系統自2017年度正式上市以來獲得市場廣泛認可,帶動公司全年銷售收入實現較快增長,故公司業績增長較快。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account